Ishares Genomics Immunology And Healthcare Etf ETF Forecast

Buy candidate since Jun 17, 2026 Gain 1.02%

The iShares Genomics Immunology and ETF price gained 0.458% on the last trading day (Monday, 22nd Jun 2026), rising from $30.56 to $30.70. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 1.26% from a day low at $30.47 to a day high of $30.86. The price has risen in 7 of the last 10 days and is up by 5.35% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 32 thousand more shares were traded than the day before. In total, 46 thousand shares were bought and sold for approximately $1.42 million.

The ETF is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect iShares Genomics Immunology and ETF with a 90% probability to be traded between $28.99 and $32.05 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and ETFS seldom manage to go directly from the bottom of a trend up to the top. ETFS turning up in the middle of a horizontal trend are therefore considered to be potential runners.

IDNA Signals & Forecast

Mostly positive signals in the chart today. The iShares Genomics Immunology and ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $30.13 and $29.56. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 8.21%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). iShares Genomics Immunology and has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for iShares Genomics Immunology and ETF

iShares Genomics Immunology and finds support from accumulated volume at $29.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $0.385 between high and low, or 1.26%. For the last week the ETF has had daily average volatility of 1.66%.

Our recommended stop-loss: $29.03 (-5.43%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 22 days ago.)

Trading Expectations (IDNA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect iShares Genomics Immunology and Healthcare ETF to open at $30.68, and during the day (based on 14 day Average True Range), to move between $30.39 and $31.01, which gives a possible trading interval of +/-$0.617 (+/-2.03%) up or down from last closing price. If iShares Genomics Immunology and Healthcare ETF takes out the full calculated possible swing range there will be an estimated 2.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $30.83 (0.42%) than the support at $29.88 (2.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is iShares Genomics Immunology and Healthcare ETF ETF A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for iShares Genomics Immunology and ETF to perform well in the short-term period. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 4.866 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $30.68 ( 0.0814%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk